Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 7/29/10  and contains information from public web pages.

Dr. Jason L. Letran

Wrong Dr. Jason L. Letran?

Urologist

Chinese General Hospital
 
Background

Employment History

  • Urologic Surgeon and Oncologist
    Chinese General Hospital
  • Urologist
    Cardinal Santos Medical Center
  • Urologic Surgeon and Oncologist
    Cardinal Santos Medical Center
  • Urologist
    University of Santo Tomas
  • Consistent Honor Student and A Product
    Royal and Pontifical University of Santo Tomas
  • Urologic Oncologist
10 Total References
Web References
PHARMA - News - GlaxoSmithKline (GSK) and Healthway Medical raising awereness on prostate cancer among Filipino men
www.pharma.focusreports.net, 29 July 2010 [cached]
According to Dr. Jason Letran, urologist at the Cardinal Santos Medical Center, University of Santo Tomas, and Chinese General Hospital, prostate cancer is the most common non-skin cancer in men worldwide. It is also the most common cancer in aging men.
The bad news is, said Dr. Letran, "one out of 5 prostate cancers will result in death within five years."
...
"PSA is the single most significant predictive indicator to determine the risk of developing prostate cancer," said Letran.
...
According to Letran and Reyes, treatment options may range from surgery to radiation, chemotherapy, medication, hormonal therapy, and active surveillance or "watchful waiting".
According to Dr. Jason ...
www.abs-cbnnews.com, 3 July 2010 [cached]
According to Dr. Jason Letran, urologist at the Cardinal Santos Medical Center, University of Santo Tomas, and Chinese General Hospital, prostate cancer is the most common non-skin cancer in men worldwide. It is also the most common cancer in aging men.
Urologist Dr. Jason Letran said prostate cancer is the most common non-skin cancer in men worldwide.
The bad news is, said Dr. Letran, "one out of 5 prostate cancers will result in death within five years."
...
"PSA is the single most significant predictive indicator to determine the risk of developing prostate cancer," said Letran.
...
According to Letran and Reyes, treatment options may range from surgery to radiation, chemotherapy, medication, hormonal therapy, and active surveillance or "watchful waiting".
Dr. Jason Letran - Erratum - Medical Observer
www.medobserver.com, 1 July 2010 [cached]
Dr. Jason Letran
...
The article "Doctors under stress" (Medical Observer, June 2010) erroneously stated the first name of Dr. Jason Letran as James. Dr. Letran is urologic surgeon and oncologist at Cardinal Santos Medical Center and Chinese General Hospital. Our apologies to Dr. Letran and our readers.
TOYM 2000 Winners
www.myusmailbox.com, 29 June 2000 [cached]
Dr. JASON L. LETRAN
...
Dr. Jason L. Letran is a 35-year-old physician with subspecialty training in Urologic Surgery and Oncology.He was a consistent honor student and a product of the Royal and Pontifical University of Santo Tomas.During his five-year residency training in Urology at the Santo Tomas University Hospital, he did the first successful Urothelial cell culture in the Philippines.This placed our country at par with the best in the world in the field of cell culture.This study also opened new doors for other medical sub-specialties that can apply their own researches with this methodology.His publications in international medical journals showed his mastery in Urologic Oncology.His interest in prostate cancer yielded studies that were able to change the way urologists think, diagnose and manage prostate cancer.His article on complex prostate specific antigen was one of the world's first works on these diagnostic agents.His studies on the technique of performing needle biopsy in the early detection and diagnosis of prostate cancer changed and influenced the manner by which urologists worldwide do the procedure.
The Medical City | Patient Partners
www.themedicalcity.com, 14 Jan 2012 [cached]
His doctor happened to be urologic oncologist Dr. Jason L. Letran. He was diagnosed with renal tumor in both of his kidneys in September 2010.
Other People with the name "Letran":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304